PlexusDx takes a precision-wellness approach by combining compounded GLP-1 options from licensed 503A pharmacies with optional genetic insights to help support informed conversations with your healthcare provider
These commitment terms are worth reviewing carefully before signing up
Similarly, mean changes in body weight were smaller: 5.3% (95% CI, 5.4% to 5.2%) for tirzepatide vs 3.3% (95% CI, 3.4% to 3.2%) for semaglutide at 3 months, 8.2% (95% CI, 8.4% to 8.0%) for tirzepatide vs 5.0% (95% CI, 5.1% to 4.8%) for semaglutide at 6 months, and 11.4% (95% CI, 12.0% to 10.8%) for tirzepatide vs 6.2% (95% CI, 6.7% to 5.8%) for semaglutide at 12 months
The two drugs work through different mechanisms and combine well
After two years, tirzepatide patients showed greater improvements in blood sugar control, weight, and waist circumference
A storage protocol that works for one pharmacy formulation might be wrong for another